본문으로 건너뛰기
← 뒤로

P2X7 receptor: a potential therapeutic target for chronic respiratory diseases.

1/5 보강
Molecular and cellular biochemistry 📖 저널 OA 25.8% 2022: 1/2 OA 2023: 0/2 OA 2024: 0/2 OA 2025: 6/17 OA 2026: 9/38 OA 2022~2026 2026 Vol.481(1) p. 139-170
Retraction 확인
출처

Huang P, Pang X, Liu X

📝 환자 설명용 한 줄

The purinergic ligand-gated ion channel 7 receptor (P2X7R) is a non-selective ion channel activated by extracellular adenosine triphosphate.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Huang P, Pang X, Liu X (2026). P2X7 receptor: a potential therapeutic target for chronic respiratory diseases.. Molecular and cellular biochemistry, 481(1), 139-170. https://doi.org/10.1007/s11010-025-05408-7
MLA Huang P, et al.. "P2X7 receptor: a potential therapeutic target for chronic respiratory diseases.." Molecular and cellular biochemistry, vol. 481, no. 1, 2026, pp. 139-170.
PMID 41099951 ↗

Abstract

The purinergic ligand-gated ion channel 7 receptor (P2X7R) is a non-selective ion channel activated by extracellular adenosine triphosphate. It promotes intracellular signal transduction by inducing Na and Ca influx and K efflux. Moreover, this receptor is involved in the regulation of the inflammatory response, oxidative stress, cell death, and immune response. P2X7R is associated with the onset and progression of various chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, lung cancer, pulmonary arterial hypertension, and pulmonary tuberculosis. In this review, we comprehensively summarize the structure and functions of P2X7R as well as its roles and potential molecular mechanisms in chronic respiratory diseases. Additionally, we explored the application of P2X7R antagonists in clinical practice. In summary, targeting P2X7R may be a new strategy for treating chronic respiratory diseases, but we should still pay attention to its dual roles, especially in lung cancer.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반